Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Panacea Biotec is a leading Indian biotechnology company with a strong track record in developing and commercializing vaccines (including WHO-prequalified pentavalent EasyFive-TT) and pharmaceuticals. It has over 120 marketed drugs across multiple therapeutic areas. Recent clinical efforts include COVID‑19 vaccine development and partnerships to manufacture Sputnik V. Its R&D pipeline covers next-generation vaccines such as dengue and anthrax candidates.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Panacea Enterprises.